Photocleavable core cross-linked polymeric micelles of polypept(o)ides and ruthenium(II) complexes

Core cross-linking of polymeric micelles has been demonstrated to contribute to enhanced stability that can improve the therapeutic efficacy. Photochemistry has the potential to provide spatial resolution and on-demand drug release. In this study, light-sensitive polypyridyl-ruthenium(II) complexes were combined with polypept(o)ides for photocleavable core cross-linked polymeric micelles. Block copolymers of polysarcosine-block-poly(glutamic acid) were synthesized by ring-opening N-carboxyanhydride polymerization and modified with aromatic nitrile-groups on the glutamic acid side chain. The modified copolymers self-assembled into micelles and were cross-linked by cis-diaquabis(2,2'-bipyridine)-ruthenium(II) ([Ru(bpy)2(H2O)2]2+) or cis-diaquabis(2,2'-biquinoline)-ruthenium(II) ([Ru(biq)2(H2O)2]2+). Depending on the flexibility and hydrophobicity of the nitrile linker, either small spherical structures (Dh 45 nm, PDI 0.11) or worm-like micelles were obtained. The cross-linking reaction did not affect the overall size distribution but induced a change in the metal-to-ligand charge transfer peak from 482 to 420 nm and 592 to 548 nm. The cross-linked micelles displayed colloidal stability after incubation with human blood plasma and during gel permeation chromatography in hexafluoroisopropanol. Light-induced cleavage of [Ru(bpy)2(H2O)2]2+ was accomplished within 300 s, while [Ru(biq)2(H2O)2]2+ could not be completely released. Analysis in HuH-7 cells revealed increased cytotoxicity via micellar delivery of [Ru(bpy)2(H2O)2]2+ but mostly irradiation damage for [Ru(biq)2(H2O)2]2+. Further evaluation in ovo confirmed stable circulation pointing towards the future development of quick-release complexes.Drug Delivery Technolog

Characterization of 9-Nitrocamptothecin Liposomes: Anticancer Properties and Mechanisms on Hepatocellular Carcinoma In Vitro and In Vivo

BACKGROUND: Hepatocellular carcinoma (HCC) is the third most common cause of cancer related mortality worldwide. 9-Nitrocamptothecin (9NC) is a potent topoisomerase-I inhibitor with strong anticancer effect. To increase the solubility and stability, we synthesized a novel 9NC loaded liposomes (9NC-LP) via incorporating 9NC into liposomes. In the present study, we determined the effects of 9NC and 9NC-LP on in vitro and in vivo, and the underlying mechanisms. METHODOLOGY/PRINCIPAL FINDINGS: We first analyzed the characteristics of 9NC-LP. Then we compared the effects of 9NC and 9NC-LP on the proliferation and apoptosis of HepG2, Bel-7402, Hep3B and L02 cells in vitro. We also investigated their anticancer properties in nude mice bearing HCC xenograft in vivo. 9NC-LP has a uniform size (around 190 nm) and zeta potential (∼-11 mV), and exhibited a steady sustained-release pattern profile in vitro. Both 9NC and 9NC-LP could cause cell cycle arrest and apoptosis in a dose-dependent and p53-dependent manner. However, this effect was not ubiquitous in all cell lines. Exposure to 9NC-LP led to increased expression of p53, p21, p27, Bax, caspase-3, caspase-8, caspase-9 and apoptosis-inducing factor, mitochondrion-associated 1 and decreased expression of Bcl-2, cyclin E, cyclin A, Cdk2 and cyclin D1. Furthermore, 9NC-LP exhibited a more potent antiproliferative effect and less side effects in vivo. Western blot analysis of the xenograft tumors in nude mice showed similar changes in protein expression in vivo. CONCLUSIONS/SIGNIFICANCE: In conclusion, 9NC and 9NC-LP can inhibit HCC growth via cell cycle arrest and induction of apoptosis. 9NC-LP has a more potent anti-tumor effect and fewer side effects in vivo, which means it is a promising reagent for cancer therapy via intravenous administration

Three-Dimensional Characterization of the Vascular Bed in Bone Metastasis of the Rat by Microcomputed Tomography (MicroCT)

BackgroundAngiogenesis contributes to proliferation and metastatic dissemination of cancer cells. Anatomy of blood vessels in tumors has been characterized with 2D techniques (histology or angiography). They are not fully representative of the trajectories of vessels throughout the tissues and are not adapted to analyze changes occurring inside the bone marrow cavities. Methodology/Principal Findings We have characterized the vasculature of bone metastases in 3D at different times of evolution of the disease. Metastases were induced in the femur of Wistar rats by a local injection of Walker 256/B cells. Microfil®, (a silicone-based polymer) was injected at euthanasia in the aorta 12, 19 and 26 days after injection of tumor cells. Undecalcified bones (containing the radio opaque vascular casts) were analyzed by microCT, and a first 3D model was reconstructed. Bones were then decalcified and reanalyzed by microCT; a second model (comprising only the vessels) was obtained and overimposed on the former, thus providing a clear visualization of vessel trajectories in the invaded metaphysic allowing quantitative evaluation of the vascular volume and vessel diameter. Histological analysis of the marrow was possible on the decalcified specimens. Walker 256/B cells induced a marked osteolysis with cortical perforations. The metaphysis of invaded bones became progressively hypervascular. New vessels replaced the major central medullar artery coming from the diaphyseal shaft. They sprouted from the periosteum and extended into the metastatic area. The newly formed vessels were irregular in diameter, tortuous with a disorganized architecture. A quantitative analysis of vascular volume indicated that neoangiogenesis increased with the development of the tumor with the appearance of vessels with a larger diameter. Conclusion This new method evidenced the tumor angiogenesis in 3D at different development times of the metastasis growth. Bone and the vascular bed can be identified by a double reconstruction and allowed a quantitative evaluation of angiogenesis upon time

Haemodynamics and Oxygenation of the Tumor Microcirculation

Abnormalities of the tumor vasculature and their consequences on the microenvironment of tumor cells impact on tumor progression and response to both blood-borne anti-cancer agents and radio-therapy, as well as making tumor blood vessels a target for therapy in their own right. Intravital microscopy of experimental tumors, most commonly grown in ‘window’ chambers, such as the dorsal skin fold chamber in mice and rats, enables investigations of tumor microcirculatory function. This is needed both to understand the molecular control of tumor vascular function and to measure the response of the vasculature to treatment. In particular, intravital microscopy enables parameters associated with blood supply, vascular permeability and oxygenation to be estimated, at high spatial and temporal resolution. In this chapter, methods used for measuring a range of these parameters, specific examples of their applications, the significance of findings and some of the limitations of the techniques are described

Real-Time Visualization and Quantitation of Vascular Permeability In Vivo: Implications for Drug Delivery

The leaky, heterogeneous vasculature of human tumors prevents the even distribution of systemic drugs within cancer tissues. However, techniques for studying vascular delivery systems in vivo often require complex mammalian models and time-consuming, surgical protocols. The developing chicken embryo is a well-established model for human cancer that is easily accessible for tumor imaging. To assess this model for the in vivo analysis of tumor permeability, human tumors were grown on the chorioallantoic membrane (CAM), a thin vascular membrane which overlays the growing chick embryo. The real-time movement of small fluorescent dextrans through the tumor vasculature and surrounding tissues were used to measure vascular leak within tumor xenografts. Dextran extravasation within tumor sites was selectively enhanced an interleukin-2 (IL-2) peptide fragment or vascular endothelial growth factor (VEGF). VEGF treatment increased vascular leak in the tumor core relative to surrounding normal tissue and increased doxorubicin uptake in human tumor xenografts. This new system easily visualizes vascular permeability changes in vivo and suggests that vascular permeability may be manipulated to improve chemotherapeutic targeting to tumors

Verbesserung der Biomaterialverträglichkeit von porösen Polyethylenimplantaten durch TNF-alpha-Inhibition in vivo

Einleitung: Für die Ausweitung des Einsatzes von Biomaterialien für die rekonstruktive Chirurgie im Mittelgesicht kommt eine immunmodulatorsiche Beschichtung poröser Polyethylenimplantate (Porengröße ~ 100-200 µm) mit einem TNF-alpha-Inhibitor in Betracht.Ziel der tierexperimentellen Studie war es, mikrovaskuläre und mechanische Integration sowie die entzündliche Reaktion in vivo zu analysieren.Methoden: Die Biomaterialien wurden mit Etanercept in einer Extrazelluär-Matrix (ECM, BD Matrigel-GFR) beschichtet. Als Kontrollen dienten unbeschichtete (K) oder ECM-beschichtete Implantate ohne Etanercept (n=6 je Gruppe). Unter Verwendung des Modells der transparenten Rückenhautkammer bei C57/Bl6-Mäusen wurde über 2 Wochen quantitative in vivo-fluoreszenzmikroskopische Untersuchungen durchgeführt.Ergebnisse: Bei den beiden beschichteten Implantaten zeigten sich signifikant erhöhte funktionelle Gefäßdichten nach Implantation in vivo. Die dynamische Desintegrationskraft als Maß für die mechanische Verankerung im Implantatbett war am Ende des Beobachtungszeitraumes in allen 3 Gruppen nicht wesentlich verändert. Allerdings zeigte sich ausschließlich nach TNF-alpha-Inhibition eine in hoch signifikante reduzierte Leukozyten-Endothelzell-Interaktion [637±32 1/(mm x mm) vs. ECM: 3939±114 1/(mm x mm) vs. K: 3574±161 1/(mm x mm); p < 0,05].Schlussfolgerung: Diese Daten zeigen, dass mittels geeigneter immunmodulatorischer Beschichtung die Bioverträglichkeit von poröser Polyethylenimplantate verbessert werden kann.Unterstützt durch: Friedrich-Baur-Stiftung, München; BiomaTiCS-Schwerpunktprogramm, Universitätsmedizin MainzDer Erstautor gibt keinen Interessenkonflikt an